venBio Global Strategic Fund II L.P. — Form D/A
venBio Global Strategic Fund II L.P. of SAN FRANCISCO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2016-03-18. The offering totals $303.0M, of which $288.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2016-03-18
- Form: D/A
- Accession: 0001634632-16-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $303.0M
- Amount sold: $288.0M
- Remaining: $15.0M
- Investors: 22
- Date of first sale: 2015-03-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-236281
Issuer
- Name: venBio Global Strategic Fund II L.P.
- CIK: 0001634632
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2015
- Address: 1700 OWENS STREET, SAN FRANCISCO, CA, 94158
- Phone: 415-522-0100
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Corey Goodman | Director | Cambridge, MA |
| Robert Adelman | Director | San Francisco, CA |
| N/A venBio Global Strategic GP II, Ltd. | Director | San Francisco, CA |
| N/A venBio Global Strategic GP II, L.P. | Director | San Francisco, CA |
| Paul Brooke | Director | San Francisco, CA |
Other filings by this issuer (2)
More